Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-07

FDA Approved: CIMETIDINE — Original Application (Bionpharma Inc.)

View source ↗

Summary

FDA approved Bionpharma Inc.'s Original Application for cimetidine, enabling the marketing of a generic H2 blocker. The action establishes a generic version of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cimetidine (CIMETIDINE)

Snippet

ORIG AP for CIMETIDINE (CIMETIDINE)